LOMAIRA
- Product NDC
- 63629-7874
- Requested package NDC
- 63629-7874-2
- 11-digit product format
- 636297874
- Labeler code
- 63629
- Product ID
- 63629-7874_05b5a6a3-9edc-4f9f-8b09-7a002fe6c387
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Phentermine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA203495
- Marketing category
- ANDA
- Marketing start
- 2016-09-12
- Marketing end
- 0000-00-00
- Substance
- PHENTERMINE HYDROCHLORIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63629-7874 | 63629-7874-2 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203495-001 | LOMAIRA | PHENTERMINE HYDROCHLORIDE | 8MG | TABLET / ORAL | AA | RS | 2016-09-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203495-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A203495-001 | LOMAIRA | 8MG | TABLET / ORAL | AA | RS | 2016-09-12 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A203495-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LOMAIRA | PHENTERMINE HYDROCHLORIDE | Calvin Scott & Co., Inc. | 0718f0f3-77f2-45d7-be12-1ed718c8b806 | 2026-05-21 | Warnings, Adverse reactions | 203495 ANDA203495 |
| LOMAIRA | PHENTERMINE HYDROCHLORIDE | KVK-TECH, INC. | cde9fb09-e5af-434d-8874-e4f9f974d893 | 2023-12-19 | Warnings, Adverse reactions | 203495 ANDA203495 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63629-7874-2 | 63629787402 | 60 TABLET in 1 BOTTLE (63629-7874-2) | 60 tablet | 2018-12-20 | 0000-00-00 | No | No | Current |